Loading stock dataβ¦
$8.56+0.06 (+0.71%)
Mobia Medical, Inc.
| Metric (USD) | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Total Revenue | $13.51Mβ | $12.07Mβ | $6.67Mβ | $5.66M |
| Gross Profit | $11.24Mβ | $9.94Mβ | $5.49Mβ | $4.65M |
| Operating Income | -$17.93Mβ | -$16.94Mβ | -$10.46Mβ | -$10.30M |
| Net Income | -$21.04Mβ | -$17.74Mβ | -$10.49Mβ | -$10.65M |
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus ...